.Pharmacolibrary.Drugs.ATC.L.L04AJ04 .Pharmacolibrary.Drugs.ATC.L.L04AJ04| name: | Sutimlimab |
| ATC code: | L04AJ04 | route: | intravenous |
| n-compartments | 2 |
Sutimlimab is a humanized monoclonal antibody that inhibits complement component C1s. It is used primarily in the treatment of cold agglutinin disease (CAD), a rare autoimmune hemolytic anemia. Sutimlimab is approved for use in adults with CAD to prevent hemolysis.
Pharmacokinetic parameters in adult patients (majority female, mean age ~70 years) with cold agglutinin disease after intravenous administration.